MedTrace Logo

A Study to Evaluate Effectiveness and Safety of Hyaluronic Acid (HA) Fillers

NCT03869450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to investigate the degree of improvement in appearance after treatment with different hyaluronic acid (HA) fillers. Product selection is based on Investigator assessment of participant tissue coverage and main treatment goal (volumizing, lifting or contouring).

Conditions

  • Volume Deficiency of the Midface

Interventions

DEVICE

Restylane Volyme

Hyaluronic based filler

DEVICE

Restylane Defyne

Hyaluronic based filler

DEVICE

Restylane Lyft Lidocaine

Hyaluronic based filler

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Q-Med AB · Galderma R&D

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-09
Primary Completion
2019-08-30
Completion
2019-08-30

Countries

  • Germany
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03869450 on ClinicalTrials.gov